Vaccines, blood, antisera, toxins and cultures in China | The Observatory of Economic Complexity

About

Exports In 2022, China exported $3.68B in Vaccines, blood, antisera, toxins and cultures, making it the 16th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 194th most exported product in China. The main destination of Vaccines, blood, antisera, toxins and cultures exports from China are: United States ($970M), Brazil ($244M), Italy ($170M), Australia ($159M), and Switzerland ($139M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of China between 2021 and 2022 were Australia ($119M), United States ($66.5M), and Switzerland ($59.7M).

Imports In 2022, China imported $16.5B in Vaccines, blood, antisera, toxins and cultures, becoming the 5th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 22nd most imported product in China. China imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($5.83B), Ireland ($3.39B), Switzerland ($2.98B), Germany ($1.92B), and Sweden ($484M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for China between 2021 and 2022 were United States ($2.03B), Ireland ($1.55B), and Switzerland ($502M).

COMPANIES In 2023, leading companies such as Costco Wholesale (2), 99 Cents Only Stores (2), and TE Connectivity (1) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from China to the United States.

Latest Trends

September 2024

About

Overview In September 2024 China's Vaccines, blood, antisera, toxins and cultures exports accounted up to $86M and imports accounted up to $1.27B, resulting in a negative trade balance of $1.19B. Between September 2023 and September 2024 the exports of China's Vaccines, blood, antisera, toxins and cultures have increased by $33.3M (63.1%) from $52.7M to $86M, while imports decreased by $-258M (-16.9%) from $1.53B to $1.27B.

Destinations In September 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States ($18.5M), United Kingdom ($13.6M), Belgium ($7.93M), Angola ($6.69M), and Switzerland ($5.65M), and were imported mostly from Germany ($274M), Switzerland ($265M), United States ($219M), France ($167M), and Belgium ($148M).

Growth In September 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Russia ($4.34M or 216%), Burma ($2.76M or 69.6%), and Sri Lanka ($1.73M or 4.08k%). In September 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from Germany ($-119M or -55.7%), Austria ($-21.8M or -70.5%), and South Korea ($-13.1M or -91.5%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (September 2023 - September 2024)$33.3M(63.1%)

IMPORT GROWTH (September 2023 - September 2024)$-258M(-16.9%)

MAIN EXPORTER (September 2024)Jiangsu Province$78.1M

MAIN DESTINATION (September 2024)United States$18.5M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for China. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download